Review article · 2021 · Open access

Current perspectives in treating negative symptoms of schizophrenia: A narrative review (Review)

Octavia Căpățînă, I. Micluția, Mihaela Fadgyas Stănculete

Experimental and Therapeutic Medicine, 21(3), 276 · Published 25 January 2021 · DOI 10.3892/etm.2021.9707

Open PDFView at the publisherCite this paper

In brief

“Current perspectives in treating negative symptoms of schizophrenia: A narrative review (Review)” is a 2021 review article by Octavia Căpățînă and 2 co-authors, published in Experimental and Therapeutic Medicine. OpenAlex counts 28 citations as of 20 November 2026, which puts it in the top 7% of works published in 2021 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Experimental and Therapeutic Medicine.

Citations
28
Most cited in
2022 (7)
Field-weighted impact
0.76
References
68
Authors
3

Abstract

The negative symptoms of schizophrenia are an unmet treatment target as currently approved treatments mostly control positive symptoms. The persistence of these symptoms holds back the patient's reinstatement in society, making them incapable of fulfilling their social, professional, or family roles. There is overwhelming research evidence suggesting that the negative symptoms of schizophrenia are associated with poorer functioning and lower quality of life than positive symptoms, confirming the need for developing new treatments for this particular category of symptoms. This present review aims to review clinical trials addressing novel pharmacological approaches addressing primary negative symptoms of schizophrenia. We overview both monotherapies, first-generation and second-generation antipsychotics, and add-on therapies, including psychostimulants, anti-inflammatory drugs, antidepressants, molecules targeting glutamatergic, cholinergic or serotonergic systems and hormones. Our findings suggest that the primary negative symptoms of schizophrenia may be mitigated by adjunctive therapies, and we highlight the pharmacological agents that have proven superior efficacy. Novel compounds such as cariprazine and MIN-101, to date, show promising results, but large clinical trials are needed to test their efficacy and safety.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Căpățînă, O., Micluția, I., & Stănculete, M. F. (2021). Current perspectives in treating negative symptoms of schizophrenia: A narrative review (Review). Experimental and Therapeutic Medicine, 21(3), 276. https://doi.org/10.3892/etm.2021.9707

MLA 9

Căpățînă, Octavia, et al. “Current perspectives in treating negative symptoms of schizophrenia: A narrative review (Review).” Experimental and Therapeutic Medicine, vol. 21, no. 3, 2021, p. 276. https://doi.org/10.3892/etm.2021.9707.

Chicago

Căpățînă, Octavia, I. Micluția, and Mihaela Fadgyas Stănculete. 2021. “Current perspectives in treating negative symptoms of schizophrenia: A narrative review (Review).” Experimental and Therapeutic Medicine 21 (3): 276. https://doi.org/10.3892/etm.2021.9707.

Harvard

Căpățînă, O., Micluția, I. and Stănculete, M. F. (2021) ‘Current perspectives in treating negative symptoms of schizophrenia: A narrative review (Review)’, Experimental and Therapeutic Medicine, 21(3), p. 276. doi:10.3892/etm.2021.9707.

IEEE

O. Căpățînă, I. Micluția, and M. F. Stănculete, “Current perspectives in treating negative symptoms of schizophrenia: A narrative review (Review),” Experimental and Therapeutic Medicine, vol. 21, no. 3, p. 276, 2021, doi: 10.3892/etm.2021.9707.

BibTeX

@article{capatina2021current,
  title     = {{Current perspectives in treating negative symptoms of schizophrenia: A narrative review (Review)}},
  author    = {Căpățînă, Octavia and Micluția, I. and Stănculete, Mihaela Fadgyas},
  journal   = {Experimental and Therapeutic Medicine},
  year      = {2021},
  volume    = {21},
  number    = {3},
  pages     = {276},
  doi       = {10.3892/etm.2021.9707},
  url       = {https://doi.org/10.3892/etm.2021.9707}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202166
202277
202355
202455
202533
202622

Its field-weighted citation impact is 0.76: it has been cited 0.76 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment

  • schizophrenia
  • negative symptoms
  • pharmacotherapy
  • adjunctive therapy
  • typical antipsychotics
  • atypical antipsychotics
  • psychostimulants
  • anti-inflammatory agents

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Căpățînă, O., Micluția, I., & Stănculete, M. F. (2021). Current perspectives in treating negative symptoms of schizophrenia: A narrative review (Review). Experimental and Therapeutic Medicine, 21(3), 276. https://doi.org/10.3892/etm.2021.9707

How many times has this paper been cited?

28 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Experimental and Therapeutic Medicine: sign in and open the PDF from this page.

Who wrote this paper?

Octavia Căpățînă, I. Micluția, Mihaela Fadgyas Stănculete.

What is the DOI of this paper?

10.3892/etm.2021.9707, permanently at https://doi.org/10.3892/etm.2021.9707. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.